Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (IST:GENIL)
Turkey · Delayed Price · Currency is TRY 166.70
-10.80 (-6.08%)
At close: Jul 16, 2025, 6:00 PM GMT+3
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Company Description
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide.
The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric.
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases.
The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
| Country | Turkey |
| Founded | 1997 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 619 |
| CEO | Abidin Gulmus |
Contact Details
Address: Mustafa Kemal District 2119 Çankaya, 06520 Turkey | |
| Phone | 90 312 219 62 19 |
| Website | genilac.com.tr |
Stock Details
| Ticker Symbol | GENIL |
| Exchange | Istanbul Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TRY |
| ISIN Number | TREGENL00024 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Abidin Gulmus | Chairman of the Board and GM |
| Semra Gulmus | Founder |
| Dr. Deniz Karagulle | Vice President of Sales and Marketing |
| Yagmur Selin Gulmus Kolay | Assistant General Manager of Strategy and Corporate Development |